Skip to content

Clinical trials

Completed Respiratory Syncytial Virus Infections trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Status: Completed Country / region: United Kingdom Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20101
20111
20122
20132
20145
20154
20162
20172
20183
20195
20203
20216
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Pfizer4
Alios Biopharma Inc.3
AstraZeneca3
Imperial College London3
Enanta Pharmaceuticals, Inc2
Gilead Sciences2
Hvivo2
MedImmune LLC2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections42
Bronchiolitis3
Influenza, Human3
Infections2
Virus Diseases2
Adenoviridae Infections1
Arrhythmias, Cardiac1
Bronchiolitis, Viral1
COVID-191
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.